Altius Institute for Biomedical Sciences is an independent, nonprofit research organization created to pursue discovery at the leading edge of modern biomedicine.

Enabled by a visionary founding investment from GlaxoSmithKline, Altius is creating a new paradigm to catalyze ground-breaking biological innovation, integrate molecular and computational science and engineering, and empower fundamental technology development to radically accelerate the leap from basic to medical breakthroughs.